Neal Walker, Director at Aclaris Therapeutics, Inc. (ACRS), sold 89,480 shares at $12.37 ($1.1M) on 2023-03-02, disclosed to the SEC on 2023-03-03.
Seasonal sale ($1.1M) by Director — this insider has traded ACRS in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.37 | 29,000 | $359K | 32.0% |
| 2 | $12.63 | 30,240 | $382K | 34.0% |
| 3 | $12.63 | 30,240 | $382K | 34.0% |
| Total | $12.55 avg | 89,480 | $1.1M | 100% |
| Filing → |
| ACRS | SELL | 2022-04-25 | $1.1M | — | Filing → |
| ACRS | SELL | 2022-03-14 | $1.8M | — | Filing → |
| ACRS | SELL | 2022-02-11 | $46K | — | Filing → |